Healthcare Equipment and Supplies
Company Overview of Neuro Kinetics, Inc.
Neuro Kinetics, Inc. provides eye tracking technology and non-invasive neuro-otologic diagnostic testing tools to audiologists, ENT’s, neuro-otologists, neuro-ophthalmologists, and neurologists around the globe. It offers I-PORTAL Neuro-Otologic Test Center, a vestibular/neuro-otologic testing system solution for diagnosing and testing patients; VEST, an operating and analysis software for neuro-otologic analysis; I-Portal Video Nystagmography for vestibular diagnostic solutions; and I-Portal Video Oculography, a digital3D eye tracking system for positional and positioning tests, and calorics and custom tests. The company also provides maintenance, training, and support services; and accesso...
128 Gamma Drive
Pittsburgh, PA 15238
Founded in 1984
Key Executives for Neuro Kinetics, Inc.
Chief Executive Officer and President
Director of Operations and Marketing
Chief Technology Officer and Vice President
Clinical Director of Audiology
Compensation as of Fiscal Year 2015.
Neuro Kinetics, Inc. Key Developments
Neuro Kinetics, Inc. Contracts with Allegheny General Hospital to Collaborate on the Analysis of Clinical Trials Underway At Two Military Medical Facilities
Jan 14 14
Neuro Kinetics, Inc. (NKI) has contracted with Allegheny General Hospital (AGH) to collaborate on the analysis of clinical trials underway at two military medical facilities. The analysis, partially funded through a contract by the U.S. Department of Defense (DoD), is gauging NKI's I-Portal eye movement-tracking technology for the diagnosis and monitoring of mild Traumatic Brain Injuries (mTBI), also known as concussions. The research builds on the company's existing I-Portal diagnostic platform, currently utilized in its equipment used clinically for detection of vestibular and equilibrium issues. The I-Portal technology measures the eye's response and reflexes to a variety of stimuli. NKI seeks to demonstrate that by using I-Portal's sophisticated yet quick and noninvasive testing of abnormal eye movements, physicians will be provided with objective data to aid in the detection of concussive symptoms. The military clinical trials are at Naval Hospital San Diego (California) and Madigan Army Medical Center (Washington State). NKI and AGH previously collaborated on a research project that tested high school athletes in Western Pennsylvania. Data collected in the previous NKI/AGH study is being included in the new analysis, as will results from existing concussion diagnostic protocols such as ImPACT and the Sports Concussion Assessment Tool (SCAT). The ultimate goal of the DoD-funded work is to accelerate validation and commercialization of NKI's oculomotor (eye movement) tests for brain injuries. NKI expects to request clearance from the U.S. Federal Drug Administration (FDA) for a new testing protocol for the diagnosis of concussions on the battlefield, at sporting events and in workplaces. (NKI's devices have FDA clearance for the clinical testing of vestibular and equilibrium disorders.) Schroeder added that while much research and regulatory review remains to be completed before the company can market a new diagnostic tool for brain injuries, the early research is promising.
Neuro Kinetics Announces Executive Appointments
Dec 5 13
Neuro Kinetics Inc. announced that Michael Saporito has been appointed as its chief financial officer. The company also said that Robert Kampmeinert has been elected to its board of directors. Saporito's most recent post was as vice president at the LifeVest division of Zoll Medical. He helped lead the turnaround of LifeVest and its subsequent acquisition by Zoll. Robert Kampmeinert retired in 2010 as chairman of Janney Montgomery Scott LLC, a major investment and investment banking firm headquartered in Philadelphia.
Similar Private Companies By Industry
Recent Private Companies Transactions
October 1, 2014
Most Searched Private Companies
Sponsored Financial Commentaries